both EMD and IHL are biotech companies, the only way to be successful in biotech is to get FDA approval, to do that a company must go through phase 1,2 and 3.
did EMD contact FDA at all ?
what are the conditions EMD are targeting?
at what stage trials are ?
answers to these questions are the reason why the current IHL market cap is 5 times EMD.
was there any company that got an FDA approval based on real world data ?
IHL strategy is the closest to GW pharma the only success story so far globally.
- Forums
- ASX - By Stock
- IHL
- Industry news
Industry news, page-350
-
-
- There are more pages in this discussion • 549 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IHL (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
LU7
LITHIUM UNIVERSE LIMITED
Alex Hanly, CEO
Alex Hanly
CEO
Previous Video
Next Video
SPONSORED BY The Market Online